TABLE 5.
Drug susceptibilities of the 183 MRSA isolates with stratification by MLST type
| MLST type (no. of isolates) | % Susceptibility for indicated druga
|
|||||||
|---|---|---|---|---|---|---|---|---|
| CM | ERM | TXT | GM | MIN | CIP | RIF | VAN | |
| ST6 (1) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| ST30 (2) | 50 | 50 | 100 | 100 | 100 | 100 | 100 | 100 |
| ST59 (147) | 14.3 | 11.6 | 99.3 | 74.1 | 99.3 | 100 | 100 | 100 |
| ST89 (7) | 0 | 0 | 100 | 100 | 100 | 85.7 | 100 | 100 |
| ST182 (1) | 100 | 0 | 100 | 100 | 100 | 100 | 100 | 100 |
| ST239 (2) | 50 | 0 | 100 | 50 | 100 | 50 | 100 | 100 |
| ST342 (1) | 100 | 0 | 100 | 100 | 100 | 100 | 100 | 100 |
| ST508 (22) | 90.9 | 54.5 | 100 | 95.4 | 100 | 100 | 100 | 100 |
| Overall (183) | 25.1 | 16.9 | 99.5 | 78.1 | 99.5 | 98.9 | 100 | 100 |
a
CM, clindamycin; ERM, erythromycin; TXT, trimethoprim-sulfamethoxazole; GM, gentamicin; MIN, minocycline; CIP, ciprofloxacin; RIF, rifampin; VAN, vancomycin.